Thomas Malley Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas Malley.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas Malley. Thomas Malley is a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a Director in Cougar Biotechnology, Inc. ($CGRB) and a Director in Kura Oncology, Inc. ($KURA) and a Director in OvaScience, Inc. ($OVAS) and a Director in BeiGene, Ltd. ($BGNE) and a Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA).
Address: 295 CLAYTON DENVER 80206 CO
Companies in which Thomas Malley is an Insider
BeiGene, Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas Malley: Director
Holdings: 9,290 shares
Current Value: $333,697
Latest Transaction: Jun 19 2020
$BGNE Market Capitalization: $1.14B
$BGNE Previous Close: $35.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cougar Biotechnology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas Malley: Director
Holdings: 0 shares
Latest Transaction: Jul 07 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kiniksa Pharmaceuticals, Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas Malley: Director
Holdings: 71,967 shares
Latest Transaction: Jul 02 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kura Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas Malley: Director
Holdings: 89,557 shares
Current Value: $555,253
Latest Transaction: Jun 23 2021
$KURA Market Capitalization: $124.74M
$KURA Previous Close: $6.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Millendo Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Thomas Malley: Director
Holdings: 204,981 shares
Current Value: $305,422
Latest Transaction: Jul 05 2017
$OVAS Market Capitalization: $55.19M
$OVAS Previous Close: $1.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas Malley: Director
Holdings: 0 shares
Latest Transaction: Jun 23 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Thomas Malley
Sentiment: All, BGNE, CGRB, KNSA, KURA, OVAS, GEVA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 21.54 | 23,000 | 495,420 | 23,000 | |
| Jul 02 2020 | KNSA | Kiniksa Pharmaceut ... | Malley Thomas | Director | Option Exercise | A | 25.48 | 18,760 | 478,005 | 18,760 | |
| Jun 26 2020 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 17.97 | 23,000 | 413,310 | 23,000 | |
| Jun 19 2020 | BGNE | BeiGene, Ltd. | Malley Thomas | Director | Option Exercise | A | 13.42 | 45,383 | 609,040 | 45,383 | |
| Jun 27 2019 | KURA | Kura Oncology, Inc ... | Malley Thomas | Director | Option Exercise | A | 19.55 | 13,000 | 254,150 | 13,000 | |
| Jun 07 2019 | BGNE | BeiGene, Ltd. | Malley Thomas | Director | Option Exercise | A | 9.23 | 64,610 | 596,350 | 64,610 | |
| May 30 2019 | KNSA | Kiniksa Pharmaceut ... | Malley Thomas | Director | Option Exercise | A | 15.47 | 18,760 | 290,217 | 18,760 |